Fig. 5
From: Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Downregulation of Kir4.1 was induced by glyoxal on rMC-1 cells. a Cell viability of rMC-1 cells treated with different doses of glyoxal. b Cell viability of 1 mM glyoxal treated-rMC-1 cells at different time points. The (c) mRNA and (d) protein expression level of Kir4.1 in rMC-1 cells treated with 1 mM glyoxal. Data are expressed as mean ± SE. n = 12 in [a, b], n = 6 in [c], n = 1 in [d], *P < 0.05